LATEST NEWS

September 17, 2020
DIAMYD MEDICAL PRESENTS RESULTS FROM DIAGNODE 2 TRIAL
September 7, 2020
DIAMYD®: ANOTHER STEP TOWARDS INDIVIDUALIZED THERAPY FOR TYPE 1 DIABETES
July 20, 2020
DIAGNODE-2: RESULTS FROM TRIAL WITH DIABETES VACCINE DIAMYD® (GAD65-ALUM) EXPECTED SEPTEMBER 2020
April 20, 2020
TYPE 1 DIABETES CARE IN COVID-19 TIMES: THE DIABETER EXPERIENCE
February 21, 2020
NEWS FROM ATTD 2020
February 4, 2020
PROF. EELCO DE KONING’S RESEARCH GROUP HAS BEEN GRANTED 1.2 MILLION EUROS FOR TWO HORIZON 2020-PROJECTS ON STEM CELL PRODUCTS
January 30, 2020
DIABETER INTERNSHIP ON THE ROLE OF PRECONCEPTION GLYCEMIC VARIABILITY IN PREGNANCY/DELIVERY IN WOMEN WITH T1D
December 18, 2019
PHASE I/II TRIAL REGENERATE-1 WITH GABA FORMULATION HAS STARTED

Recently published press release from Diamyd
December 17, 2019
A NEW WAY OF LOOKING AT HETEROGENEITY IN T1D: THE ENDOTYPE

Recently published in Diabetes Care
December 3, 2019
SCREENING FOR TYPE 1 DIABETES?

Update from ISPAD 2019

Friends of Diabeter

Diabeter.nl

Diabeter Nederland BV
Blaak 6
3011 TA Rotterdam
E: research@diabeter.nl
T: 088-280 7277
F: 088-280 9299
© 2019 Diabeter | Terms of Use | Privacy Statement